{"mainPropery":{"diseaseId":8208,"diseaseName":"HTLV-1 associated myelopathy/tropical spastic paraparesis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/8208/htlv-1-associated-myelopathytropical-spastic-paraparesis","synonyms":["HAM/TSP","Human T-cell leukemia virus type 1 associated myelopathy/tropical spastic paraparesis","Tropical spastic paraparesis (formerly)"],"synonyms-with-source":[{"name":"HAM/TSP"},{"name":"Human T-cell leukemia virus type 1 associated myelopathy/tropical spastic paraparesis"},{"name":"Tropical spastic paraparesis (formerly)"}],"identifiers":[{"identifierType":"UMLS","identifierId":"C0030481"}]},"diseaseCategories":[{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases"}],"organizations":[],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=%28htlv-1%5BTitle/Abstract%5D%20AND%20associated%5BTitle/Abstract%5D%20AND%20myelopathy%5BTitle/Abstract%5D%29%20OR%20%28tropical%5BTitle/Abstract%5D%20AND%20spastic%5BTitle/Abstract%5D%20AND%20paraparesis%5BTitle/Abstract%5D%29%20AND%20%28%28Clinical%20Trial%5Bptyp%5D%20OR%20Editorial%5Bptyp%5D%20OR%20Letter%5Bptyp%5D%20OR%20Meta-Analysis%5Bptyp%5D%20OR%20Practice%20Guideline%5Bptyp%5D%20OR%20Randomized%20Controlled%20Trial%5Bptyp%5D%20OR%20Review%5Bptyp%5D%29%20AND%20English%5Blang%5D%20AND%20%222001/03/20%22%5BPDat%5D%20%3A%20%222011/03/17%22%5BPDat%5D%29&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss HTLV-1 associated myelopathy/tropical spastic paraparesis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22HTLV-1+associated+myelopathy/tropical+spastic+paraparesis%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to HTLV-1 associated myelopathy/tropical spastic paraparesis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":553,"resourceId":1305,"resourceName":"HTLV","descriptionText":"Oh U, Jacobson S. <a href='http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2610848/?tool=pubmed ' target='_blank'>Treatment of HTLV-I-associated myelopathy/tropical spastic paraparesis: toward rational targeted therapy</a>. <em>Neurol Clin</em>. 2008 Aug;26(3):781-97, ix-x. ","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":1054,"resourceId":366,"resourceName":"National Multiple Sclerosis Society","descriptionText":"The <a href='http://www.nationalmssociety.org/What-is-MS/Related-Conditions/HTLV-I-Associated-Myelopathy-(HAM)' target='_blank'>National Multiple Sclerosis Society</a> is a global network of adult and pediatric neurologists, basic scientists, clinicians, representatives of MS societies and other relevant professional organizations, whose vision is to improve worldwide healthcare, education and research in pediatric multiple sclerosis. Click on the link to learn more.","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1203/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='https://www.ninds.nih.gov/Disorders/All-Disorders/Tropical-Spastic-Paraparesis-Information-Page' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1166055-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1542,"resourceId":2170,"resourceName":"RePORTER","descriptionText":"The <a href='http://projectreporter.nih.gov/reporter.cfm' target='_blank'>Research Portfolio Online Reporting Tool (RePORT)</a> provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research.  Although these projects may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies, enter the disease name in the \"Text Search\" box.  Then click \"Submit Query\".","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1545,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The <a href='https://www.merckmanuals.com/home/brain,-spinal-cord,-and-nerve-disorders/spinal-cord-disorders/tropical-spastic-paraparesis-htlv-1%E2%80%93associated-myelopathy-tsp-ham' target='_blank'>Merck Manuals Online Medical Library</a> provides information on this condition for patients and caregivers.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1700,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The&nbsp;<a href='http://www.merckmanuals.com/professional/neurologic-disorders/spinal-cord-disorders/tropical-spastic-paraparesis-htlv-1%E2%80%93associated-myelopathy-tsp-ham' target='_blank'>Merck Manual</a> for health care professionals provides information on&nbsp;HTLV-1 associated myelopathy/tropical spastic paraparesis.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":376,"questionText":"What is&nbsp;HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)?","answerText":"<strong>HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) </strong>is a progressive disease of the nervous system that affects less than 2% of people with <a href=\"https://rarediseases.info.nih.gov/diseases/9645/human-t-cell-leukemia-virus-type-1\" target=\"_blank\">HTLV-1 infection</a>.&nbsp;Signs and symptoms vary but may include slowly progressive weakness and spasticity of one or both legs, exaggerated reflexes, muscle contractions in the ankle, and lower back pain. Other features may include urinary incontinence and minor sensory changes, especially burning or prickling sensations and loss of vibration sense.[13568] The reason some people with HTLV-1 infection&nbsp;develop HAM/TSTP is not well understood.[13568] Treatment generally aims to control the specific symptoms, as there is no standard treatment available.[13569] <a href=\"http://www.macmillan.org.uk/cancerinformation/cancertreatment/treatmenttypes/biologicaltherapies/interferon.aspx\" target=\"_blank\">Interferon alpha</a> may be beneficial over short periods, and some aspects of the disease may be improved with <a href=\"https://www.mssociety.org.uk/what-is-ms/treatments-and-therapies/licensed-disease-modifying-drugs/beta-interferon-and-glatiramer-acetate\" target=\"_blank\">interferon beta</a>.[273] Other medications may include i<span style=\"font-size: 12pt;\">mmune globulin,  oral </span><span class=\"resolvedDrug\" style=\"font-size: 12pt;\">corticosteroids, and muscle relaxers such as&nbsp;<span class=\"resolvedDrug\" style=\"font-size: 12pt;\">baclofen</span><span style=\"font-size: 12pt;\"> or </span><span class=\"resolvedDrug\" style=\"font-size: 12pt;\">tizanidine.[13569][272]</span></span>","dateModified":"2017-07-12T00:00:00"},"basicQuestions":[{"questionId":4210,"questionText":"What are the signs and symptoms of HTLV-1 associated myelopathy/tropical spastic paraparesis?","answerText":"Signs and symptoms of&nbsp;HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)&nbsp;vary but may include:[13568][273][272]<br />\r\n<ul>\r\n    <li>Slowly progressive weakness and spasticity of one or both legs</li>\r\n    <li>Exaggerated reflexes (hyperreflexia)</li>\r\n    <li>Stiff muscles</li>\r\n    <li>Muscle contractions in the ankle (ankle clonus)</li>\r\n    <li>Lower back pain</li>\r\n    <li>A&nbsp;'weak' bladder and/or urinary incontinence</li>\r\n    <li>Minor sensory changes, especially burning or prickling sensations and loss of vibration sense</li>\r\n</ul>","dateModified":"2017-07-12T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":272,"authors":"Rubin M","articleTitle":"Tropical Spastic Paraparesis/HTLV-1â€“Associated Myelopathy (TSP/HAM)","bookWebsiteJournalTitle":"Merck Manual","date":"October, 2016","volume":"","pages":"","url":"http://www.merckmanuals.com/professional/neurologic-disorders/spinal-cord-disorders/tropical-spastic-paraparesis-htlv-1%E2%80%93associated-myelopathy-tsp-ham","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":273,"authors":"","articleTitle":"Tropical Spastic Paraparesis Information Page","bookWebsiteJournalTitle":"National Institute of Neurological Disorders and Stroke","date":"","volume":"","pages":"","url":"https://www.ninds.nih.gov/Disorders/All-Disorders/Tropical-Spastic-Paraparesis-Information-Page","dateAccessed":"2017-07-12T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13568,"authors":"Scadden DT, Freedman AR, Robertson P","articleTitle":"Human T-lymphotropic virus type I: Disease associations, diagnosis, and treatment","bookWebsiteJournalTitle":"UpToDate","date":"February 16, 2016","volume":"","pages":"","url":"http://www.uptodate.com/contents/human-t-lymphotropic-virus-type-i-disease-associations-diagnosis-and-treatment","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":377,"questionText":"How might HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) be treated?","answerText":"Treatment generally aims to control the specific symptoms, as there is no standard treatment available.[13569]&nbsp;<a href=\"http://www.macmillan.org.uk/cancerinformation/cancertreatment/treatmenttypes/biologicaltherapies/interferon.aspx\" target=\"_blank\">Interferon alpha</a>&nbsp;may be beneficial over short periods, and some aspects of the disease may be improved with&nbsp;<a href=\"https://www.mssociety.org.uk/what-is-ms/treatments-and-therapies/licensed-disease-modifying-drugs/beta-interferon-and-glatiramer-acetate\" target=\"_blank\">interferon beta</a>.[273] Stiff and spastic muscles may be treated with&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682530.html\" target=\"_blank\">lioresal</a>&nbsp;or&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601121.html\" target=\"_blank\">tizanidine</a>, and urinary dysfunction may be treated with&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682141.html\" target=\"_blank\">oxybutynin</a>.[273] Corticosteroids were reported to slow progression in one case series and reduce neurologic disability in another. However, others have reported no such benefit with corticosteroids and there have been no randomized clinical trials.[13568]","dateModified":"2017-07-12T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":273,"authors":"","articleTitle":"Tropical Spastic Paraparesis Information Page","bookWebsiteJournalTitle":"National Institute of Neurological Disorders and Stroke","date":"","volume":"","pages":"","url":"https://www.ninds.nih.gov/Disorders/All-Disorders/Tropical-Spastic-Paraparesis-Information-Page","dateAccessed":"2017-07-12T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13568,"authors":"Scadden DT, Freedman AR, Robertson P","articleTitle":"Human T-lymphotropic virus type I: Disease associations, diagnosis, and treatment","bookWebsiteJournalTitle":"UpToDate","date":"February 16, 2016","volume":"","pages":"","url":"http://www.uptodate.com/contents/human-t-lymphotropic-virus-type-i-disease-associations-diagnosis-and-treatment","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"},{"referenceId":13569,"authors":"Sandbrink F","articleTitle":"Tropical Myeloneuropathies Treatment & Management","bookWebsiteJournalTitle":"Medscape Reference","date":"January, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1166055-treatment","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":21281,"abbreviatedInquiry":"Is there treatment or a cure for HAM/TSP or for HTLV-1 in general?","caseQuestions":[{"questionId":7978,"questionText":"How&nbsp;might human T-cell leukemia virus, type&nbsp;1 be treated?&nbsp;","answerText":"No cure or treatment exists for human T-cell leukemia virus, type 1 (HTLV-1). Management is focused on early detection and preventing the spread of HTLV-1 to others. Screening blood doners, promoting safe sex and discouraging needle sharing can decrease the number of new infections. Mother-to-child transmission can be reduced by screening pregnant women so infected mothers can avoid breastfeeding.[7948][7945]","dateModified":"2014-12-10T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":7945,"authors":"","articleTitle":"HTLV Type I and Type II","bookWebsiteJournalTitle":"NORD","date":"May 2012","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1203/viewAbstract","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7948,"authors":"David T Scadden, MD; Andrew R Freedman, FRCP; Paul Robertson, MRCP","articleTitle":"Human T-lymphotropic virus type I: Disease associations, diagnosis, and treatment","bookWebsiteJournalTitle":"UpToDate","date":"March 2014","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":378,"questionText":"Is there research being conducted on possible treatment options for human T-cell lymphotrophic virus associated myelopathy/tropical spastic paraparesis (HAM/TSP)?","answerText":"The U.S. National Institutes of Health, through the National Library of Medicine, developed <a href=\"http://www.clinicaltrials.gov/\" target=\"_blank\">ClinicalTrials.gov</a> to provide patients, family members, and members of the public with current information on clinical research studies. To find trials enrolling&nbsp;people with HAM/TSP, <a href=\"http://clinicaltrials.gov/ct2/results?term=tropical+spastic+paraparesis\" target=\"_blank\">click here</a>. After you click on a study, review its \"eligibility\" criteria to determine its appropriateness. Use the study&rsquo;s contact information to learn more. Check the ClinicalTrials.gov&nbsp;Web site&nbsp;often for regular updates.<br />\r\n<br />\r\nIf you are interested in enrolling in a clinical trial, you can find helpful general information on clinical trials by <a href=\"http://clinicaltrials.gov/ct2/info/understand\" target=\"_blank\">clicking here</a>. <br />\r\n<br />\r\nA tutorial about clinical trials that can also help answer your questions can be found at the following link from the National Library of Medicine:<br />\r\n<a href=\"http://www.nlm.nih.gov/medlineplus/tutorials/clinicaltrials/htm/video.htm\" target=\"_blank\">http://www.nlm.nih.gov/medlineplus/tutorials/clinicaltrials/htm/video.htm</a><br />","dateModified":"2014-12-01T00:00:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"HTLV-1_associated_myelopathy_tropical_spastic_paraparesis"}